Skip to main content

Pinealon vs Glutathione (GSH)

Both Pinealon and Glutathione (GSH) are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.

Pinealon

Evidence C

Pinealon (EDR)

A short tripeptide developed in Russia for cognitive aging and oxidative stress. Limited Western clinical evidence.

View full Pinealon profile →

Glutathione (GSH)

Evidence B

Reduced L-Glutathione

Technically a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary antioxidant. Often grouped with peptide therapy in IV/compounded form for liver support and oxidative stress.

View full Glutathione (GSH) profile →

Side-by-Side

AttributePinealonGlutathione (GSH)
Evidence GradeCB
FDA StatusNot FDA-approved — Russian-origin research peptideNot FDA-approved as therapeutic — sold as supplement; intravenous use compounded
Typical Dose5–10 mg daily for 10–20 days (subcutaneous, cycled)200–600 mg sublingual / 600–2400 mg IV (compounded)
Clinics Indexed9312
Categoriescognitive, longevityantioxidant, longevity

Key reported benefits — Pinealon

  • Cognitive function (preclinical)
  • Reduced oxidative damage
  • Sleep/circadian effects

Key reported benefits — Glutathione (GSH)

  • Master antioxidant
  • Liver detoxification support
  • Oxidative stress reduction

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons